Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8.08%895.12M | 3.97%3.53B | 1.49%2.58B | 1.41%1.68B | 2.90%828.2M | -14.08%3.4B | -16.37%2.54B | -22.46%1.66B | -22.65%804.88M | -13.39%3.96B |
| Operating income | 8.08%895.12M | 3.97%3.53B | 1.49%2.58B | 1.41%1.68B | 2.90%828.2M | -14.08%3.4B | -16.37%2.54B | -22.46%1.66B | -22.65%804.88M | -13.39%3.96B |
| Operating expenses | -10.08%-463.04M | -1.62%-1.88B | 4.44%-1.33B | 7.57%-849.85M | 6.39%-420.65M | 23.74%-1.85B | 26.17%-1.39B | 32.97%-919.44M | 32.18%-449.36M | 18.86%-2.43B |
| Gross profit | 6.02%432.08M | 6.79%1.65B | 8.61%1.26B | 12.54%834.02M | 14.64%407.56M | 1.34%1.54B | -0.53%1.16B | -3.73%741.07M | -5.96%355.52M | -2.95%1.52B |
| Selling expenses | 57.23%-125.81K | 20.20%-1.05M | 15.17%-795.43K | 12.31%-560.85K | 13.31%-294.16K | 5.62%-1.32M | 10.46%-937.71K | 9.55%-639.59K | -54.45%-339.34K | -46.89%-1.39M |
| Administrative expenses | -11.66%-59.35M | -6.14%-247.17M | -1.75%-155.45M | -4.99%-105.22M | -5.80%-53.15M | -7.88%-232.86M | -7.12%-152.77M | -10.56%-100.22M | -18.86%-50.23M | -9.63%-215.86M |
| Research and development expenses | -61.86%-1.94M | -10.60%-7.85M | 1.88%-3.64M | 0.24%-2.46M | 4.05%-1.2M | 3.73%-7.1M | 6.43%-3.71M | 2.08%-2.47M | -12.54%-1.25M | 15.29%-7.37M |
| Profit from asset sales | ---- | -1,573.46%-87.47K | -15,850.76%-119.11K | -116.45%-53.01 | -99.94%9 | -99.86%5.94K | -73.98%756.21 | -72.13%322.2 | 1,199.21%15.02K | 164.20%4.35M |
| Impairment and provision | 21.99%-19.88M | -49.34%-256.37M | -94.32%-36.04M | -257.80%-49.67M | -799.92%-25.49M | -171.53%-171.68M | 22.09%-18.55M | 11.40%-13.88M | 59.27%-2.83M | -359.82%-63.23M |
| -Other impairment is provision | 21.99%-19.88M | -49.34%-256.37M | -94.32%-36.04M | -257.80%-49.67M | -799.92%-25.49M | -171.53%-171.68M | 22.09%-18.55M | 11.40%-13.88M | 59.27%-2.83M | -359.82%-63.23M |
| Special items of operating profit | 31.11%36.36M | 21.04%111.1M | 21.45%79.92M | 33.24%49.24M | 53.64%27.73M | 26.99%91.79M | 21.94%65.8M | 9.23%36.95M | 13.98%18.05M | 2.94%72.28M |
| Operating profit | 9.10%366.89M | 1.65%1.17B | 9.04%1.08B | 9.73%687.14M | 11.45%336.3M | -7.65%1.15B | -0.33%992.84M | -5.49%626.22M | -7.79%301.73M | -7.89%1.25B |
| Financing income | -32.87%1.01M | -40.89%5.08M | -41.04%3.88M | -35.60%2.91M | -31.43%1.51M | -36.76%8.6M | -37.97%6.58M | 163.10%4.52M | -36.91%2.2M | 202.56%13.6M |
| Financing cost | 12.53%-85.51M | 16.44%-378.87M | 17.49%-287.59M | 19.03%-193.14M | 20.05%-97.76M | 6.50%-453.4M | 3.34%-348.55M | -1.54%-238.55M | -4.09%-122.29M | 2.16%-484.91M |
| Special items of earning before tax | 943.38%363.22K | -54.48%975.37K | -64.79%480.65K | -63.26%384.04K | -91.46%34.81K | -29.39%2.14M | 5.29%1.37M | 24.44%1.05M | 15.77%407.59K | 102.51%3.03M |
| Earning before tax | 17.89%282.46M | 11.86%789.92M | 22.81%797.7M | 26.92%496.33M | 32.24%239.6M | -9.13%706.14M | 0.53%649.52M | -10.12%391.06M | -15.07%181.19M | -12.85%777.09M |
| After-tax profit from continuing operations | 11.85%218.58M | 0.63%604.53M | 21.58%648.05M | 23.12%398.58M | 33.00%195.43M | -9.45%600.74M | -5.27%533.02M | -14.83%323.73M | -17.74%146.94M | -15.42%663.47M |
| Earning after tax | 11.85%218.58M | 0.63%604.53M | 21.58%648.05M | 23.12%398.58M | 33.00%195.43M | -9.45%600.74M | -5.27%533.02M | -14.83%323.73M | -17.74%146.94M | -15.42%663.47M |
| Minority profit | 15.22%12.06M | -182.79%-12.97M | -26.57%21.57M | 3.08%21.34M | 29.45%10.46M | -54.19%15.66M | 9.59%29.38M | 29.12%20.71M | 0.63%8.08M | -13.86%34.19M |
| Profit attributable to shareholders | 11.66%206.53M | 5.54%617.5M | 24.39%626.48M | 24.49%377.23M | 33.21%184.96M | -7.02%585.08M | -6.02%503.64M | -16.76%303.03M | -18.60%138.85M | -15.51%629.28M |
| Basic earnings per share | 15.38%0.15 | 4.76%0.44 | 25.00%0.45 | 22.73%0.27 | 30.00%0.13 | -6.67%0.42 | -5.26%0.36 | -15.38%0.22 | -16.67%0.1 | -15.09%0.45 |
| Diluted earnings per share | 7.69%0.14 | 4.88%0.43 | 20.00%0.42 | 23.81%0.26 | 30.00%0.13 | -4.65%0.41 | -2.78%0.35 | -12.50%0.21 | -9.09%0.1 | -10.42%0.43 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | PwC Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.